未登录.png)
分享.png)
收藏Quality control indices for standardized diagnosis and treatment of esophageal cancer in China (2022 edition)
Zhang, Ruixiang; Wang, Zhen; Kang, Xiaozheng; Wang, Xin; Zhang, Bo; Ng, Hoi-loi; Xue, Liyan; Yang, Wenjing; Shi, Liming; Wang, Hui; Wang, Lvhua; Li, Yin 分享 收藏 Progression-free survival as surrogate endpoint of overall survival in esophageal squamous cell carcinoma: a real-world data and literature-based analysisHan, Weiming; Wang, Lan; Li, Chen; Chen, Junqiang; Zhang, Wencheng; Wang, Xin; Pang, Qingsong; Zhao, Yidian; Sun, Xinchen; Zhang, Kaixian; Li, Gaofeng; Li, Ling; Qiao, Xueying; Liu, Miaoling; Wang, Yadi; Deng, Lei; Wang, Wenqing; Bi, Nan; Zhang, Tao; Deng, Wei; Ni, Wenjie; Chang, Xiao; Zhou, Zongmei; Liang, Jun; Feng, Qinfu; Wang, Lvhua; Chen, Dongfu; Lv, Jima; Zhu, Shuchai; Han, Chun; Xiao, Zefen 分享 收藏 Survival benefit of surgery in patients with clinical T4 esophageal cancer who achieved complete or partial response after neoadjuvant chemoradiotherapy or radiotherapy新辅助放化疗或放疗后获得完全或部分缓解的临床T4期食管癌患者手术的生存获益Gao, Lin-Rui; Li, Chen; Han, Weiming; Ni, Wenjie; Deng, Wei; Tan, Lijun; Zhou, Zongmei; Chen, Dongfu; Feng, Qinfu; Liang, Jun; Lv, Jima; Wang, Wenqing; Liu, Wenyang; Deng, Lei; Wang, Xin; Zhang, Tao; Wang, Jianyang; Zhai, Yirui; Bi, Nan; Wang, Lvhua; Hui, Zhouguang; Li, Ye-Xiong; Xiao, Zefen 分享 收藏 Recurrence risk stratification based on a competing-risks nomogram to identify patients with esophageal cancer who may benefit from postoperative radiotherapyChang, Xiao; Chen, Junqiang; Zhang, Wencheng; Yang, Jinsong; Yu, Shufei; Deng, Wei; Ni, Wenjie; Zhou, Zongmei; Chen, Dongfu; Feng, Qinfu; Lv, Jima; Liang, Jun; Hui, Zhouguang; Wang, Lvhua; Lin, Yu; Chen, Xiaohui; Xue, Qi; Mao, Yousheng; Gao, Yushun; Wang, Dali; Feng, Feiyue; Gao, Shugeng; He, Jie; Xiao, Zefen 分享 收藏 分享 收藏 Chemoradiotherapy with extended nodal irradiation and/or erlotinib in locally advanced oesophageal squamous cell cancer: long-term update of a randomised phase 3 trialXie, Congying; Jing, Zhao; Luo, Honglei; Jiang, Wei; Ma, Li; Hu, Wei; Zheng, Anping; Li, Duojie; Ding, Lingyu; Zhang, Hongyan; Xie, Conghua; Lian, Xilong; Du, Dexi; Chen, Ming; Bian, Xiuhua; Tan, Bangxian; Xia, Bing; Xie, Ruifei; Liu, Qing; Wang, Lvhua; Wu, Shixiu 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Randomised phase III trial of concurrent chemoradiotherapy with extended nodal irradiation and erlotinib in patients with inoperable oesophageal squamous cell cancerWu, Shi-Xiu; Wang, Lv-Hua; Luo, Hong-Lei; Xie, Cong-Ying; Zhang, Xue-Bang; Hu, Wei; Zheng, An-Ping; Li, Duo-Jie; Zhang, Hong-Yan; Xie, Cong-Hua; Lian, Xi-Long; Du, De-Xi; Chen, Ming; Bian, Xiu-Hua; Tan, Bang-Xian; Jiang, Hao; Zhang, Hong-Bo; Wang, Jian-Hua; Jing, Zhao; Xia, Bing; Zhang, Ni; Zhang, Ping; Li, Wen-Feng; Zhao, Fu-Jun; Tian, Zhi-Feng; Liu, Hui; Huang, Ke-Wei; Hu, Jin; Xie, Rui-Fei; Du, Lin; Li, Gang 分享 收藏 分享 收藏 DCE-MRI Perfusion and Permeability Parameters as predictors of tumor response to CCRT in Patients with locally advanced NSCLCTao, Xiuli; Wang, Lvhua; Hui, Zhouguang; Liu, Li; Ye, Feng; Song, Ying; Tang, Yu; Men, Yu; Lambrou, Tryphon; Su, Zihua; Xu, Xiao; Han Ouyang; Wu, Ning 分享 收藏 分享 收藏 Residual lymph node status is an independent prognostic factor in esophageal squamous cell Carcinoma with pathologic T0 after preoperative radiotherapy残余淋巴结状态是术前放疗后病理T0食管鳞癌的独立预后因素Wang, Qifeng; Yu, Shufei; Xiao, Zefen; Liu, Xiao; Zhang, Wencheng; Zhang, Xun; He, Jie; Sun, Kelin; Xu, Ting; Feng, Qinfu; Zhou, Zongmei; Wang, Lvhua; Yin, Weibo 分享 收藏 Cetuximab in combination with chemoradiotherapy in Chinese patients with non-resectable, locally advanced esophageal squamous cell carcinoma: A prospective, multicenter phase II trailMeng, Xue; Wang, Jianhua; Sun, Xindong; Wang, Lvhua; Ye, Ming; Feng, Pingbo; Zhu, Guangying; Lu, You; Han, Chun; Zhu, Shuchai; Liao, Zhongxing; Yu, Jinming 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
.png){kind=icon}
